Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Lepage

Showing results (71-80 of 88) with videos related to

Pageof 9
Sort By:
ESMO Open|October 30, 2025
Negative hyperselection of patients with stage III colon cancer receiving anti-EGFR-based adjuvant treatmentM Ambrosini, H Blons, S Garinet, et al.
Alimentary Pharmacology & Therapeutics|April 9, 2005
Is the management of hepatitis C patients appropriate? A population-based studyC Hatem, A Minello, S Bresson-Hadni, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
Genetic and transcriptomic analyses of early-onset colon cancer (EOCC): a <i>post hoc</i> analysis of 2973 patients from two adjuvant randomized trialsA Gandini, C Gallois, H Blons, et al.
Diagnostic and Interventional Imaging|August 19, 2015
Ipsilateral breast cancer recurrence after Deep Inferior Epigastric Perforator (DIEP) flap reconstruction: Incidence and radiological presentationJ A Farras Roca, T H Dao, L Lantieri, et al.
Cancer Biomarkers : Section a of Disease Markers|February 22, 2020
Loss of SMARCB1 expression in colon carcinomaS Melloul, J-F Mosnier, J Masliah-Planchon, et al.
Alimentary Pharmacology & Therapeutics|April 18, 2014
Idarubicin-loaded beads for chemoembolisation of hepatocellular carcinoma: results of the IDASPHERE phase I trialM Boulin, P Hillon, J P Cercueil, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 4, 2016
The multidisciplinary management of gastro-oesophageal junction tumours: European Society of Digestive Oncology (ESDO): Expert discussion and report from the 16th ESMO World Congress on Gastrointestinal Cancer, BarcelonaJ-L Van Laethem, F Carneiro, M Ducreux, et al.
Annals of Surgical Oncology|June 19, 2019
Influence of Molecular Status on Recurrence Site in Patients Treated for a Stage III Colon Cancer: a Post Hoc Analysis of the PETACC-8 TrialM Bruzzi, E Auclin, R Lo Dico, et al.
Annals of Surgery|July 30, 2019
Perioperative FOLFOX 4 Versus FOLFOX 4 Plus Cetuximab Versus Immediate Surgery for High-Risk Stage II and III Colon Cancers: A Phase II Multicenter Randomized Controlled Trial (PRODIGE 22)M Karoui, A Rullier, G Piessen, et al.
European Journal of Cancer (Oxford, England : 1990)|October 22, 2018
FOLFIRINOX as induction treatment in rectal cancer patients with synchronous metastases: Results of the FFCD 1102 phase II trialJ B Bachet, O Lucidarme, C B Levache, et al.
Pageof 9

Showing results (71-80 of 88) with videos related to

Sort By:
Pageof 9
ESMO Open|October 30, 2025
Negative hyperselection of patients with stage III colon cancer receiving anti-EGFR-based adjuvant treatmentM Ambrosini, H Blons, S Garinet, et al.
Alimentary Pharmacology & Therapeutics|April 9, 2005
Is the management of hepatitis C patients appropriate? A population-based studyC Hatem, A Minello, S Bresson-Hadni, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
Genetic and transcriptomic analyses of early-onset colon cancer (EOCC): a <i>post hoc</i> analysis of 2973 patients from two adjuvant randomized trialsA Gandini, C Gallois, H Blons, et al.
Diagnostic and Interventional Imaging|August 19, 2015
Ipsilateral breast cancer recurrence after Deep Inferior Epigastric Perforator (DIEP) flap reconstruction: Incidence and radiological presentationJ A Farras Roca, T H Dao, L Lantieri, et al.
Cancer Biomarkers : Section a of Disease Markers|February 22, 2020
Loss of SMARCB1 expression in colon carcinomaS Melloul, J-F Mosnier, J Masliah-Planchon, et al.
Alimentary Pharmacology & Therapeutics|April 18, 2014
Idarubicin-loaded beads for chemoembolisation of hepatocellular carcinoma: results of the IDASPHERE phase I trialM Boulin, P Hillon, J P Cercueil, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 4, 2016
The multidisciplinary management of gastro-oesophageal junction tumours: European Society of Digestive Oncology (ESDO): Expert discussion and report from the 16th ESMO World Congress on Gastrointestinal Cancer, BarcelonaJ-L Van Laethem, F Carneiro, M Ducreux, et al.
Annals of Surgical Oncology|June 19, 2019
Influence of Molecular Status on Recurrence Site in Patients Treated for a Stage III Colon Cancer: a Post Hoc Analysis of the PETACC-8 TrialM Bruzzi, E Auclin, R Lo Dico, et al.
Annals of Surgery|July 30, 2019
Perioperative FOLFOX 4 Versus FOLFOX 4 Plus Cetuximab Versus Immediate Surgery for High-Risk Stage II and III Colon Cancers: A Phase II Multicenter Randomized Controlled Trial (PRODIGE 22)M Karoui, A Rullier, G Piessen, et al.
European Journal of Cancer (Oxford, England : 1990)|October 22, 2018
FOLFIRINOX as induction treatment in rectal cancer patients with synchronous metastases: Results of the FFCD 1102 phase II trialJ B Bachet, O Lucidarme, C B Levache, et al.
Pageof 9